City

Clinical trials near Greenville, United States

Active studies with a listed research site in Greenville, United States.

13active studies

7recruiting now

5countries represented

87largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Obesity, OverweightCondition

LY3305677, LY3841136Treatment

Argentina, United States56 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT06143956See eligibility →

Recruiting nowPhase 3

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Obesity, OverweightCondition

Maridebart cafraglutide, PlaceboTreatment

Australia, Japan87 locations

AmgenSponsor

Updated 2026-09-03 · NCT07684235See eligibility →

Recruiting nowPhase 1, Phase 2

HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

Pulmonary Hypertension, Heart Failure With Preserved Ejection FractionCondition

HS235, PlaceboTreatment

United States1 locations

35Pharma IncSponsor

Updated 2026-08-17 · NCT07123779See eligibility →

Recruiting nowPhase 2

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, ModerateCondition

Tirzepatide, PlaceboTreatment

United States9 locations

T. John Winhusen, PhDSponsor

Updated 2026-08-11 · NCT06651177See eligibility →

Recruiting nowPhase 2

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Overweight, ObesityCondition

Macupatide, EloralintideTreatment

United States40 locations

Eli Lilly and CompanySponsor

Updated 2026-08-06 · NCT07589608See eligibility →

Recruiting nowNot applicable

Pregnancy Exercise Mode Effect on Childhood Obesity

Pregnancy, Overweight and ObesityCondition

Exercise ModesTreatment

United States1 locations

East Carolina UniversitySponsor

Updated 2026-06-04 · NCT04805502See eligibility →

Recruiting nowNot applicable

Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis

Metabolic InflexibilityCondition

Weight loss surgeryTreatment

United States1 locations

East Carolina UniversitySponsor

Updated 2025-08-07 · NCT04320264See eligibility →

Opening soonNot applicable

Implementation Facilitation of Exercise is Medicine Greenville

Physical Inactivity, DyslipidemiaCondition

Clinic Implementation FacilitationTreatment

United States1 locations

University of South CarolinaSponsor

Updated 2026-04-02 · NCT07340580See eligibility →

Active, not recruitingPhase 2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

ObesityCondition

Trevogrumab-Part A, Trevogrumab-Part B and Part CTreatment

Puerto Rico, United States60 locations

Regeneron PharmaceuticalsSponsor

Updated 2026-09-01 · NCT06299098See eligibility →

Active, not recruitingNot applicable

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

Obesity Type 2 Diabetes Mellitus, Obesity (Disorder)Condition

GLP-1 TherapyTreatment

United States2 locations

University of South CarolinaSponsor

Updated 2026-07-23 · NCT07313384See eligibility →

Active, not recruitingPhase 2

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Obesity, OverweightCondition

LY3841136, TirzepatideTreatment

Argentina, United States52 locations

Eli Lilly and CompanySponsor

Updated 2026-07-17 · NCT06603571See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

ObesityCondition

Ribupatide, PlaceboTreatment

United States35 locations

KaileraSponsor

Updated 2026-07-15 · NCT07458269See eligibility →

Active, not recruitingPhase 2, Phase 3

The Medically Reproducing Bariatric Surgery (MRB) II Study

Type 2 Diabetes, ObesityCondition

Very Low Calorie DietTreatment

United States1 locations

Durham VA Medical CenterSponsor

Updated 2025-02-07 · NCT06363747See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Greenville, United States

Current studies

Related cities